Will The Magnificent 7 Stocks Go Up This Year?
2025 was another banner year for the Magnificent Seven stocks,…
Buy
62
USPH Quote, Financials, Valuation and Earnings
Last price:
$84.02
Seasonality move
:
0.51%
Day range:
$80.07 - $84.16
52-week range:
$62.77 - $93.50
Dividend yield:
2.14%
P/E ratio:
35.32x
P/S ratio:
1.68x
P/B ratio:
2.54x
Volume:
216.7K
Avg. volume:
177.1K
1-year change:
-5.73%
Market cap:
$1.3B
Revenue:
$671.3M
EPS (TTM):
$2.38
Analysts' Opinion
-
Consensus RatingU.S. Physical Therapy, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 2 Buy ratings, 1 Hold rating, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $105.33, U.S. Physical Therapy, Inc. has an estimated upside of 25.46% from its current price of $83.96.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $98.00 representing 100% downside risk from its current price of $83.96.
Fair Value
-
According to the consensus of 3 analysts, U.S. Physical Therapy, Inc. has 25.46% upside to fair value with a price target of $105.33 per share.
USPH vs. S&P 500
-
Over the past 5 trading days, U.S. Physical Therapy, Inc. has overperformed the S&P 500 by 4.79% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
U.S. Physical Therapy, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
U.S. Physical Therapy, Inc. has grown year-over-year revenues for 18 quarters straight. In the most recent quarter U.S. Physical Therapy, Inc. reported revenues of $197.1M.
Earnings Growth
-
U.S. Physical Therapy, Inc. has grown year-over-year earnings for 4 quarters straight. In the most recent quarter U.S. Physical Therapy, Inc. reported earnings per share of $0.48.
Enterprise value:
1.8B
EV / Invested capital:
--
Price / LTM sales:
1.68x
EV / EBIT:
23.95x
EV / Revenue:
2.42x
PEG ratio (5yr expected):
0.23x
EV / Free cash flow:
31.47x
Price / Operating cash flow:
21.85x
Enterprise value / EBITDA:
18.33x
Gross Profit (TTM):
$132.4M
Return On Assets:
5.55%
Net Income Margin (TTM):
8.47%
Return On Equity:
8.6%
Return On Invested Capital:
6.17%
Operating Margin:
9.89%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $591.2M | $645.7M | $758.7M | $168M | $197.1M | |
| Gross Profit | $109.4M | $111.4M | $132.4M | $26.5M | $33.1M | |
| Operating Income | $68.8M | $65.3M | $76.5M | $14.7M | $19.5M | |
| EBITDA | $84.2M | $82.4M | $100M | $19.1M | $25.3M | |
| Diluted EPS | $1.71 | $0.93 | $2.38 | $0.39 | $0.48 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $79.4M | $112.9M | $228.5M | $204.9M | $138.4M | |
| Total Assets | $630.1M | $799.7M | $1B | $1B | $1.2B | |
| Current Liabilities | $81.7M | $81.5M | $82.4M | $115.3M | $115.1M | |
| Total Liabilities | $201.3M | $332.9M | $342M | $358.5M | $413.8M | |
| Total Equity | $428.8M | $466.8M | $668.2M | $670.7M | $782.4M | |
| Total Debt | $107.1M | $231.1M | $225.9M | $219.5M | $266.4M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $73.2M | $83.4M | $70.9M | $22.4M | $20.4M | |
| Cash From Investing | -$80.7M | -$64M | -$127.5M | -$6.1M | -$12.4M | |
| Cash From Financing | $117.3M | -$50.1M | -$29.3M | -$12.2M | -$11M | |
| Free Cash Flow | $65.1M | $74.4M | $58.2M | $19.9M | $16.1M | |
USPH
Sector
Market Cap
$1.3B
$28.1M
Price % of 52-Week High
89.8%
51.87%
Dividend Yield
2.14%
0%
Shareholder Yield
1.34%
-1.59%
1-Year Price Total Return
-5.73%
-17.31%
Beta (5-Year)
1.290
0.495
Dividend yield:
2.14%
Annualized payout:
$1.76
Payout ratio:
94.46%
Growth streak:
4 years
Technicals
8-day SMA
Buy
Level
$81.08
200-day SMA
Buy
Level
$78.35
Bollinger Bands (100)
Buy
Level
75.6 - 87.7
Chaikin Money Flow
Buy
Level
23.3M
20-day SMA
Buy
Level
$80.39
Relative Strength Index (RSI14)
Buy
Level
60.00
ADX Line
Buy
Level
16.35
Williams %R
Sell
Level
-16.6862
50-day SMA
Buy
Level
$77.80
MACD (12, 26)
Buy
Level
1.16
25-day Aroon Oscillator
Buy
Level
80
On Balance Volume
Neutral
Level
17.2M
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.815)
Buy
CA Score
(Annual)
Level (-0.2776)
Buy
Beneish M-Score
(Annual)
Level (-2.4854)
Buy
Momentum Score
Level (3)
Buy
Ohlson Score
Level (-0.6434)
Buy
Piotroski F Score
(Annual)
Level (6)
Buy
Quality Ratio Score
Level (5)
Buy
Fundamental Score
Level (9)
Revenue Forecast
Earnings per Share Forecast
Company Profile
U.S. Physical Therapy, Inc. operates outpatient physical therapy clinics, which provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries. It operates through the Physical Therapy Operations and Industrial Injury Prevention Services segments. The Physical Therapy Operations segment consists of physical therapy and occupational therapy clinics that provide pre-and postoperative care and treatment for orthopedic related disorders, sports-related injuries, preventive care, rehabilitation of injured workers and neurological injuries. The Industrial Injury Prevention Services segment includes onsite injury prevention and rehabilitation, performance optimization and ergonomic assessments. The company was founded in 1990 and is headquartered in Houston, TX.
Stock Forecast FAQ
In the current month, USPH has received 2 Buy ratings 1 Hold ratings, and 0 Sell ratings. The USPH average analyst price target in the past 3 months is $105.33.
-
Where Will U.S. Physical Therapy, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that U.S. Physical Therapy, Inc. share price will rise to $105.33 per share over the next 12 months.
-
What Do Analysts Say About U.S. Physical Therapy, Inc.?
Analysts are divided on their view about U.S. Physical Therapy, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that U.S. Physical Therapy, Inc. is a Sell and believe this share price will drop from its current level to $98.00.
-
What Is U.S. Physical Therapy, Inc.'s Price Target?
The price target for U.S. Physical Therapy, Inc. over the next 1-year time period is forecast to be $105.33 according to 3 Wall Street analysts, 2 of them rate the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.
-
Is USPH A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for U.S. Physical Therapy, Inc. is a Buy. 2 of 3 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of USPH?
You can purchase shares of U.S. Physical Therapy, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase U.S. Physical Therapy, Inc. shares.
-
What Is The U.S. Physical Therapy, Inc. Share Price Today?
U.S. Physical Therapy, Inc. was last trading at $84.02 per share. This represents the most recent stock quote for U.S. Physical Therapy, Inc.. Yesterday, U.S. Physical Therapy, Inc. closed at $83.96 per share.
-
How To Buy U.S. Physical Therapy, Inc. Stock Online?
In order to purchase U.S. Physical Therapy, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get USPH Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
USPH
Sector
P/E ratio
35.32x
24.20x
PEG ratio
0.23x
-0.01x
P/B ratio
2.54x
1.84x
Price / LTM sales
1.68x
1.60x
Growth Metrics
USPH
Sector
Revenue growth
17.32%
4.51%
Earnings growth
23.61%
10.7%
Revenue (5-year growth)
6.85%
6.45%
Earnings forecast
$0.67
-$0.19
Profitability
USPH
Sector
Profitability FY 2024
$130M
$3.5M
Return on invested capital
6.17%
-32.3%
Return on assets
5.55%
-28.57%
Return on equity
8.6%
-38.09%
Earnings Date
Last Earnings Date
Nov
5
Next Earnings Date
Feb
25
Estimated Next Earnings Date
Feb
4
Balance Sheet
USPH
Sector
Total cash
$31.1M
$26M
Short term investments
--
$25.7M
Total assets
$1.2B
$76.4M
Long term debt
$266.4M
$3.2M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Did Planet Labs Stock Rally So Much?
Satellite imaging startup Planet Labs (NYSE:PL), after years of disappointing…
Why Did Stan Druckenmiller Sell Broadcom Stock?
In Q3, legendary macro investor Stan Druckenmiller sold his entire…
Stock Ideas
Buy
52
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
65
Is GOOG Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Buy
51
Is GOOGL Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Alerts
Buy
100
ATGL alert for Jan 10
Alpha Technology Group Ltd. [ATGL] is up 47.05% over the past day.
Buy
71
NAIL alert for Jan 10
Direxion Daily Homebuilders & Supplies Bull 3X Shs [NAIL] is up 18.52% over the past day.
Buy
54
LGIH alert for Jan 10
LGI Homes, Inc. [LGIH] is up 13.81% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
